Philippe Gabriel Steg, M.D ., Arnoud van Hof ‘t, M.D., Ph.D., Christian W. Hamm, M.D., Peter Clemmensen, M.D., Ph.D.D., Ph.D., Pierre Coste, M.D., Jurrien Ten Berg, M.D., Ph.D., Pierre Van Grunsven, M.D., Gerrit Jan Eggink, M.D., Lutz Nibbe, M.D., Uwe Zeymer, M.D., Marco Campo dell’ Orto, M.D., Holger Nef, M.D., Jacob Steinmetz, M.D., Ph.D., Louis Soulat, M.D., Kurt Huber, M.D., Efthymios N. Deliargyris, M.D., Debra Bernstein, Ph.D., Diana Schuette, Ph.D., Jayne Prats, Ph.D., Tim Clayton, M.Sc., Stuart Pocock, Ph.D., Martial Hamon, M.D., and Patrick Goldstein, M.D. For the EUROMAX Investigators: Bivalirudin Started during Crisis Transport for Primary PCI Primary percutaneous coronary intervention , which is the standard of care for the treating patients with ST-segment elevation myocardial infarction ,1,2 requires adjunctive antithrombotic treatment with anticoagulants and antiplatelet brokers.

Thompson today announced $498 million in awards to claims, territories and four main metropolitan areas to strengthen the capability of hospitals and other health care facilities to respond to bioterror attacks, infectious diseases, and organic disasters that could cause mass casualties. These grants are a significant addition to national security because hospitals play such a critical role in identifying and responding to a terrorist attack, an infectious disease outbreak, and organic disasters, Secretary Thompson said. States and communities can use these funds to boost emergency care in virtually any health crisis, whether the supply is a bioterror assault or other infectious disease outbreaks like SARS or West Nile virus, or any organic disaster like a hurricane or flood.